Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients

BACKGROUND: Prostate cancer antigen 3 (PCA3) is a prostate cancer diagnostic biomarker that has been clinically validated. The limitations of the diagnostic role of PCA3 in initial biopsy and the prognostic role are not well established. Here, we elucidate the limitations of tissue PCA3 to predict h...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshalalfa, Mohammed, Verhaegh, Gerald W., Gibb, Ewan A., Santiago-Jiménez, Maria, Erho, Nicholas, Jordan, Jennifer, Yousefi, Kasra, Lam, Lucia L.C., Kolisnik, Tyler, Chelissery, Jijumon, Seiler, Roland, Ross, Ashley E., Karnes, R. Jeffrey, Schaeffer, Edward M., Lotan, Tamara T., Den, Robert B., Freedland, Stephen J., Davicioni, Elai, Klein, Eric A., Schalken, Jack A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584206/
https://www.ncbi.nlm.nih.gov/pubmed/28881605
http://dx.doi.org/10.18632/oncotarget.15133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584206/
https://www.ncbi.nlm.nih.gov/pubmed/28881605
http://dx.doi.org/10.18632/oncotarget.15133

Ejemplares similares